Goodwin Procter advised Laronde on the deal. Laronde announced its $440 million Series B Financing to advance the development of its eRNA platform and a broad pipeline...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here